| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Amyloid-beta precursor protein | 0 | 9 | 0 | 9 |
| dopamine D1 receptor | 2 | 0 | 0 | 2 |
| thioredoxin reductase | 13 | 0 | 0 | 13 |
| GLS protein | 9 | 0 | 0 | 9 |
| Thrombopoietin | 5 | 0 | 0 | 5 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 10 | 0 | 0 | 10 |
| cytochrome P450 2D6 isoform 1 | 6 | 0 | 0 | 6 |
| cytochrome P450 2C19 precursor | 7 | 0 | 0 | 7 |
| ras-related protein Rab-9A | 6 | 0 | 0 | 6 |
| histone acetyltransferase KAT2A isoform 1 | 7 | 0 | 0 | 7 |
| lethal factor (plasmid) | 8 | 0 | 0 | 8 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Spike glycoprotein | 10 | 0 | 1 | 11 |
| ATP-dependent phosphofructokinase | 7 | 0 | 0 | 7 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 1 | 3 |
| 5-hydroxytryptamine receptor 1A | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 1F | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 0 | 1 | 1 |
| Sodium-dependent serotonin transporter | 0 | 0 | 1 | 1 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 5A | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 5B | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
| EWS/FLI fusion protein | 16 | 0 | 0 | 16 |
| Apoptosis regulator Bcl-2 | 0 | 4 | 2 | 6 |
| Bcl-2-like protein 1 | 0 | 3 | 0 | 3 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 3 | 0 | 3 |
| Aspartyl/asparaginyl beta-hydroxylase | 0 | 1 | 0 | 1 |
| Bcl-2-related protein A1 | 0 | 2 | 0 | 2 |
| Bcl-2-like protein 2 | 0 | 2 | 0 | 2 |
| Bcl2-associated agonist of cell death | 0 | 2 | 0 | 2 |
| TDP1 protein | 24 | 0 | 0 | 24 |
| chromobox protein homolog 1 | 12 | 0 | 0 | 12 |
| geminin | 15 | 0 | 0 | 15 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 8 | 0 | 0 | 8 |
| RAR-related orphan receptor gamma | 23 | 0 | 0 | 23 |
| GLI family zinc finger 3 | 23 | 0 | 0 | 23 |
| AR protein | 28 | 0 | 0 | 28 |
| thioredoxin glutathione reductase | 8 | 0 | 0 | 8 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 10 | 0 | 0 | 10 |
| glucocorticoid receptor [Homo sapiens] | 21 | 0 | 0 | 21 |
| retinoic acid nuclear receptor alpha variant 1 | 21 | 0 | 0 | 21 |
| estrogen-related nuclear receptor alpha | 26 | 0 | 0 | 26 |
| estrogen nuclear receptor alpha | 31 | 0 | 0 | 31 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 17 | 0 | 0 | 17 |
| IDH1 | 6 | 0 | 0 | 6 |
| euchromatic histone-lysine N-methyltransferase 2 | 19 | 0 | 0 | 19 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 8 | 0 | 0 | 8 |
| thyroid hormone receptor beta isoform 2 | 17 | 0 | 0 | 17 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 21 | 0 | 0 | 21 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| lamin isoform A-delta10 | 13 | 0 | 0 | 13 |
| Polyphenol oxidase 2 | 0 | 3 | 0 | 5 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 0 | 1 | 1 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 1 | 0 | 2 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 11 | 0 | 0 | 11 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 12 | 0 | 0 | 12 |
| Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
| interleukin 8 | 5 | 0 | 0 | 5 |
| phosphopantetheinyl transferase | 10 | 0 | 0 | 10 |
| SMAD family member 2 | 8 | 0 | 0 | 8 |
| ATAD5 protein, partial | 9 | 0 | 0 | 9 |
| Fumarate hydratase | 13 | 0 | 0 | 13 |
| SMAD family member 3 | 8 | 0 | 0 | 8 |
| Microtubule-associated protein tau | 7 | 0 | 0 | 7 |
| nuclear receptor subfamily 1, group I, member 3 | 20 | 0 | 0 | 20 |
| retinoid X nuclear receptor alpha | 20 | 0 | 0 | 20 |
| farnesoid X nuclear receptor | 11 | 0 | 0 | 11 |
| pregnane X nuclear receptor | 19 | 0 | 0 | 19 |
| G | 6 | 0 | 0 | 6 |
| polyprotein | 13 | 0 | 0 | 13 |
| P53 | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 14 | 0 | 0 | 14 |
| peroxisome proliferator activated receptor gamma | 16 | 0 | 0 | 16 |
| arylsulfatase A | 6 | 0 | 0 | 6 |
| aryl hydrocarbon receptor | 12 | 0 | 0 | 12 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 18 | 0 | 0 | 18 |
| thyroid stimulating hormone receptor | 11 | 0 | 0 | 11 |
| activating transcription factor 6 | 11 | 0 | 0 | 11 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 13 | 0 | 0 | 13 |
| Histone H2A.x | 11 | 0 | 0 | 11 |
| Bloom syndrome protein isoform 1 | 8 | 0 | 0 | 8 |
| peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
| hemoglobin subunit beta | 2 | 0 | 0 | 2 |
| cellular tumor antigen p53 isoform a | 7 | 0 | 0 | 7 |
| heat shock protein beta-1 | 9 | 0 | 0 | 9 |
| DNA polymerase iota isoform a (long) | 8 | 0 | 0 | 8 |
| peripheral myelin protein 22 | 6 | 0 | 0 | 6 |
| survival motor neuron protein isoform d | 9 | 0 | 0 | 9 |
| cytochrome P450 3A4 isoform 1 | 12 | 0 | 0 | 12 |
| M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
| muscleblind-like protein 1 isoform 1 | 5 | 0 | 0 | 5 |
| muscarinic acetylcholine receptor M1 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit pi | 12 | 0 | 0 | 12 |
| ATP-binding cassette sub-family C member 3 | 0 | 15 | 0 | 15 |
| Multidrug resistance-associated protein 4 | 0 | 15 | 0 | 15 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 13 | 0 | 0 | 13 |
| Bile salt export pump | 0 | 24 | 0 | 24 |
| Interferon beta | 15 | 0 | 0 | 15 |
| HLA class I histocompatibility antigen, B alpha chain | 6 | 0 | 0 | 6 |
| Cellular tumor antigen p53 | 20 | 0 | 0 | 20 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 12 | 0 | 0 | 12 |
| Gamma-aminobutyric acid receptor subunit delta | 12 | 0 | 0 | 12 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 12 | 0 | 0 | 12 |
| Glutamate receptor 2 | 14 | 0 | 0 | 14 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 12 | 0 | 0 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 12 | 0 | 0 | 12 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 12 | 0 | 0 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 12 | 0 | 0 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 12 | 0 | 0 | 12 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 12 | 0 | 0 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 12 | 0 | 0 | 12 |
| Nuclear receptor ROR-gamma | 9 | 1 | 1 | 11 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 12 | 0 | 0 | 12 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 12 | 0 | 0 | 12 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 12 | 0 | 0 | 12 |
| GABA theta subunit | 12 | 0 | 0 | 12 |
| Inositol hexakisphosphate kinase 1 | 6 | 0 | 0 | 6 |
| Canalicular multispecific organic anion transporter 1 | 0 | 16 | 0 | 17 |
| ATPase family AAA domain-containing protein 5 | 13 | 0 | 0 | 13 |
| Ataxin-2 | 15 | 0 | 0 | 15 |
| Gamma-aminobutyric acid receptor subunit epsilon | 12 | 0 | 0 | 12 |
| Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
| cytochrome P450 2C9, partial | 6 | 0 | 0 | 6 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 9 | 0 | 0 | 9 |
| Chain A, HADH2 protein | 9 | 0 | 0 | 9 |
| Chain B, HADH2 protein | 9 | 0 | 0 | 9 |
| Chain A, 2-oxoglutarate Oxygenase | 10 | 0 | 0 | 10 |
| Chain A, Cruzipain | 4 | 0 | 0 | 4 |
| USP1 protein, partial | 8 | 0 | 0 | 8 |
| aldehyde dehydrogenase 1 family, member A1 | 18 | 0 | 0 | 18 |
| vitamin D3 receptor isoform VDRA | 7 | 0 | 0 | 7 |
| DNA polymerase kappa isoform 1 | 7 | 0 | 0 | 7 |
| caspase-1 isoform alpha precursor | 3 | 0 | 0 | 3 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| Inositol monophosphatase 1 | 5 | 0 | 0 | 5 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 6 | 0 | 8 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 4 | 0 | 6 |
| Chain H, Proteasome component PUP1 | 0 | 1 | 0 | 1 |
| Chain I, Proteasome component PUP3 | 0 | 1 | 0 | 1 |
| Chain K, Proteasome component PRE2 | 0 | 1 | 0 | 1 |
| Chain L, Proteasome component C5 | 0 | 1 | 0 | 1 |
| Chain K, Proteasome component PRE2 | 0 | 1 | 0 | 1 |
| Chain L, Proteasome component C5 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-11 | 0 | 3 | 0 | 3 |
| PPM1D protein | 8 | 0 | 0 | 8 |
| caspase 7, apoptosis-related cysteine protease | 6 | 0 | 0 | 6 |
| estrogen receptor 2 (ER beta) | 12 | 0 | 0 | 12 |
| progesterone receptor | 14 | 0 | 0 | 14 |
| caspase-3 | 6 | 0 | 0 | 6 |
| nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
| Caspase-7 | 4 | 0 | 0 | 4 |
| caspase-3 | 4 | 0 | 0 | 4 |
| 26S proteasome non-ATPase regulatory subunit 11 | 0 | 2 | 0 | 2 |
| 26S proteasome non-ATPase regulatory subunit 12 | 0 | 2 | 0 | 2 |
| 26S proteasome non-ATPase regulatory subunit 14 | 0 | 3 | 0 | 3 |
| Proteasome subunit alpha type-7 | 0 | 3 | 0 | 3 |
| Histone deacetylase 3 | 0 | 1 | 0 | 1 |
| 26S proteasome non-ATPase regulatory subunit 3 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 12 | 0 | 4 | 0 | 5 |
| Prothrombin | 0 | 4 | 2 | 7 |
| Chymotrypsinogen A | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 1 | 0 | 12 | 0 | 14 |
| Carbonic anhydrase 2 | 0 | 12 | 0 | 14 |
| Carbonic anhydrase 3 | 0 | 3 | 0 | 4 |
| Cathepsin B | 0 | 2 | 0 | 2 |
| Neutrophil elastase | 0 | 4 | 0 | 4 |
| Cathepsin G | 0 | 3 | 0 | 3 |
| Lysosomal protective protein | 0 | 2 | 0 | 2 |
| Chymotrypsinogen B | 0 | 2 | 0 | 2 |
| 26S proteasome regulatory subunit 6A | 0 | 2 | 0 | 2 |
| Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-1 | 0 | 3 | 0 | 4 |
| Carbonic anhydrase 4 | 0 | 4 | 0 | 5 |
| Carbonic anhydrase 6 | 0 | 4 | 0 | 5 |
| Chymase | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-1 | 0 | 3 | 0 | 3 |
| Proteasome subunit alpha type-2 | 0 | 3 | 0 | 3 |
| Proteasome subunit alpha type-3 | 0 | 3 | 0 | 3 |
| Proteasome subunit alpha type-4 | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-8 | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-8 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-9 | 0 | 3 | 0 | 3 |
| Proteasome subunit alpha type-5 | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-4 | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-6 | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-5 | 0 | 6 | 0 | 7 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 0 | 4 |
| 26S proteasome regulatory subunit 7 | 0 | 2 | 0 | 2 |
| Lon protease homolog, mitochondrial | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-10 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 7 | 0 | 3 | 0 | 4 |
| 26S proteasome regulatory subunit 6B | 0 | 2 | 0 | 2 |
| 26S proteasome non-ATPase regulatory subunit 8 | 0 | 2 | 0 | 2 |
| Proteasome subunit beta type-3 | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-2 | 0 | 3 | 0 | 4 |
| 26S proteasome non-ATPase regulatory subunit 7 | 0 | 2 | 0 | 2 |
| 26S proteasome non-ATPase regulatory subunit 4 | 0 | 2 | 0 | 2 |
| 26S proteasome complex subunit SEM1 | 0 | 2 | 0 | 2 |
| Proteasome subunit alpha type-6 | 0 | 3 | 0 | 3 |
| 26S proteasome regulatory subunit 4 | 0 | 2 | 0 | 2 |
| 26S proteasome regulatory subunit 8 | 0 | 2 | 0 | 2 |
| 26S proteasome regulatory subunit 10B | 0 | 2 | 0 | 2 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Nuclear factor NF-kappa-B p100 subunit | 0 | 1 | 0 | 1 |
| Transcription factor p65 | 0 | 1 | 0 | 1 |
| 26S proteasome non-ATPase regulatory subunit 2 | 0 | 2 | 0 | 2 |
| Histone deacetylase 1 | 0 | 1 | 0 | 1 |
| 26S proteasome non-ATPase regulatory subunit 6 | 0 | 2 | 0 | 2 |
| Proteasomal ubiquitin receptor ADRM1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 9 | 0 | 5 | 0 | 6 |
| ATP-dependent Clp protease proteolytic subunit | 0 | 2 | 2 | 4 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
| NACHT, LRR and PYD domains-containing protein 3 | 0 | 2 | 0 | 2 |
| Proteasome subunit alpha-type 8 | 0 | 3 | 0 | 3 |
| Histone deacetylase 2 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-7 | 0 | 3 | 0 | 3 |
| 26S proteasome non-ATPase regulatory subunit 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 15 | 0 | 2 | 0 | 3 |
| Histone deacetylase 8 | 0 | 1 | 1 | 2 |
| Histone deacetylase 6 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 4 | 0 | 5 |
| 26S proteasome non-ATPase regulatory subunit 13 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 0 | 4 |
| Proteasome subunit beta type-2 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-1 | 0 | 1 | 0 | 1 |
| Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 3 | 0 | 3 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 6 | 0 | 0 | 6 |
| DNA polymerase beta | 4 | 0 | 0 | 4 |
| flap endonuclease 1 | 7 | 0 | 0 | 7 |
| DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
| neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Arginase | 0 | 3 | 0 | 3 |
| Pancreatic triacylglycerol lipase | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 1 | 5 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
| Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 1 | 2 | 0 | 4 |
| Adenosine receptor A2a | 0 | 2 | 0 | 3 |
| Prostaglandin G/H synthase 2 | 0 | 7 | 0 | 7 |
| Mu-type opioid receptor | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 0 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 3 | 0 | 3 |
| Melatonin receptor type 1A | 0 | 0 | 1 | 1 |
| Melatonin receptor type 1B | 0 | 0 | 1 | 1 |
| Death-associated protein kinase 1 | 0 | 3 | 0 | 3 |
| Beta-secretase 1 | 0 | 4 | 0 | 4 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
| Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Putative Glycine Betaine-binding Abc Transporter Protein | 0 | 0 | 1 | 1 |
| Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Choline-binding protein | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 5 | 0 | 5 |
| Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
| Choline O-acetyltransferase | 0 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-9 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
| High affinity choline transporter 1 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-10 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
| importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
| mitogen-activated protein kinase 1 | 6 | 0 | 0 | 6 |
| snurportin-1 | 2 | 0 | 0 | 2 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
| plasminogen precursor | 4 | 0 | 0 | 4 |
| urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 7 | 1 | 11 |
| Cytochrome P450 3A4 | 0 | 7 | 0 | 7 |
| Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
| Luciferase | 8 | 0 | 0 | 8 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| PAX8 | 0 | 0 | 0 | 2 |
| pregnane X receptor | 5 | 0 | 0 | 5 |
| hypoxia-inducible factor 1 alpha subunit | 7 | 0 | 0 | 7 |
| Smad3 | 7 | 0 | 0 | 7 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| 67.9K protein | 4 | 0 | 0 | 4 |
| glucocerebrosidase | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9 precursor | 6 | 0 | 0 | 6 |
| thyroid hormone receptor beta isoform a | 7 | 0 | 0 | 7 |
| atrial natriuretic peptide receptor 2 precursor | 3 | 0 | 0 | 3 |
| steroidogenic factor 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Tubulin alpha-1A chain | 0 | 2 | 1 | 3 |
| Tubulin beta chain | 0 | 2 | 1 | 3 |
| Plasma kallikrein | 0 | 0 | 0 | 2 |
| Tubulin beta-4A chain | 0 | 2 | 2 | 5 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
| Tubulin beta chain | 0 | 2 | 2 | 5 |
| Tubulin alpha-3C chain | 0 | 2 | 2 | 5 |
| Serine/threonine-protein kinase pim-1 | 0 | 3 | 1 | 5 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
| Histamine H2 receptor | 7 | 0 | 0 | 7 |
| Tubulin alpha-1B chain | 0 | 2 | 2 | 5 |
| Tubulin alpha-4A chain | 0 | 2 | 2 | 5 |
| Tubulin beta-4B chain | 0 | 2 | 2 | 5 |
| Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
| Tubulin beta-3 chain | 0 | 2 | 2 | 5 |
| Tubulin beta-2A chain | 0 | 2 | 2 | 5 |
| Tubulin polymerization-promoting protein | 0 | 0 | 1 | 1 |
| Tubulin beta-8 chain | 0 | 2 | 2 | 5 |
| Tubulin beta-2B chain | 0 | 3 | 0 | 3 |
| Tubulin alpha-3E chain | 0 | 2 | 2 | 5 |
| Tubulin alpha-1A chain | 0 | 2 | 2 | 5 |
| Similar to alpha-tubulin isoform 1 | 0 | 2 | 0 | 2 |
| Similar to alpha-tubulin isoform 1 | 0 | 2 | 0 | 2 |
| CREB-binding protein | 2 | 1 | 0 | 3 |
| Tubulin alpha-1C chain | 0 | 2 | 2 | 5 |
| Tubulin beta-6 chain | 0 | 2 | 2 | 5 |
| Tubulin beta-2B chain | 0 | 2 | 2 | 5 |
| Tubulin beta-1 chain | 0 | 2 | 2 | 5 |
| B2 bradykinin receptor | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 4 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| Beta-galactosidase | 0 | 1 | 0 | 2 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 0 | 2 | 0 | 2 |
| PH domain leucine-rich repeat-containing protein phosphatase 2 | 0 | 1 | 0 | 1 |
| Chymotrypsin-C | 0 | 2 | 0 | 2 |
| regulator of G-protein signaling 4 | 5 | 0 | 0 | 5 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 7 | 0 | 0 | 7 |
| atrial natriuretic peptide receptor 1 precursor | 3 | 0 | 0 | 3 |
| Glucocorticoid receptor | 0 | 10 | 2 | 17 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 10 | 0 | 10 |
| Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
| Glycine receptor subunit beta | 0 | 10 | 0 | 10 |
| Glycine receptor subunit alpha-2 | 0 | 10 | 0 | 10 |
| Glycine receptor subunit alpha-3 | 0 | 10 | 0 | 10 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| TAR DNA-binding protein 43 | 3 | 0 | 0 | 3 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
| Transthyretin | 0 | 3 | 6 | 13 |
| Albumin | 0 | 3 | 4 | 9 |
| Interleukin-8 | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 6 | 0 | 7 |
| Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
| UDP-glucuronosyltransferase 1-6 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 3 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
| C-X-C chemokine receptor type 1 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
| Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 3 | 0 | 4 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
| P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A7 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A10 | 0 | 1 | 0 | 1 |
| electroneutral potassium-chloride cotransporter KCC2 | 0 | 0 | 1 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 7 | 0 | 0 | 7 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 5 | 0 | 0 | 5 |
| nuclear receptor ROR-gamma isoform 1 | 8 | 0 | 0 | 8 |
| High mobility group protein B1 | 0 | 0 | 2 | 2 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 5 | 1 | 0 | 6 |
| 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase | 0 | 2 | 0 | 2 |
| STAT3, partial | 0 | 1 | 0 | 1 |
| alpha-galactosidase | 3 | 0 | 0 | 3 |
| NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
| signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 2 | 0 | 2 |
| Integrin beta-3 | 5 | 0 | 0 | 5 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 5 | 0 | 0 | 5 |
| Replicase polyprotein 1ab | 0 | 4 | 1 | 5 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 4 | 1 | 0 | 5 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| Single-stranded DNA cytosine deaminase | 2 | 0 | 0 | 2 |
| Ornithine transcarbamylase, mitochondrial | 0 | 1 | 0 | 1 |
| Farnesyl pyrophosphate synthase | 0 | 4 | 0 | 4 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| Capsid protein | 0 | 0 | 1 | 1 |
| Chain A, Troponin C, slow skeletal and cardiac muscles | 0 | 0 | 1 | 1 |
| Chain A, Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 0 | 1 | 1 |
| Chain A, POLYMERASE PA | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 1 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 4 | 0 | 0 | 4 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| galactokinase | 2 | 0 | 0 | 2 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| POsterior Segregation | 0 | 0 | 1 | 1 |
| Prostaglandin E synthase | 0 | 1 | 0 | 1 |
| Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
| Polycomb protein EED | 0 | 0 | 1 | 1 |
| NAD kinase | 0 | 2 | 1 | 3 |
| Urokinase-type plasminogen activator | 0 | 3 | 0 | 3 |
| Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
| Polymerase acidic protein | 0 | 1 | 1 | 2 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 2 | 0 | 2 |
| Plasminogen activator inhibitor 1 | 0 | 1 | 0 | 1 |
| Heme oxygenase 1 | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
| 72 kDa type IV collagenase | 0 | 4 | 0 | 4 |
| Hepatocyte growth factor receptor | 0 | 3 | 0 | 3 |
| Matrilysin | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 3 | 0 | 3 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 2 | 0 | 2 |
| Alpha-amylase 1A | 0 | 2 | 0 | 2 |
| Microtubule-associated protein tau | 0 | 2 | 0 | 2 |
| 60 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| CPG DNA methylase | 0 | 1 | 0 | 1 |
| Lethal factor | 0 | 1 | 0 | 1 |
| Phosphoglycerate mutase 1 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Heme oxygenase 2 | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 0 | 1 | 1 |
| DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 2 | 0 | 2 |
| Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
| Signal transducer and activator of transcription 1-alpha/beta | 0 | 0 | 1 | 1 |
| DNA repair protein RAD52 homolog | 0 | 2 | 0 | 2 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-14 | 0 | 2 | 0 | 2 |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | 0 | 1 | 0 | 1 |
| Squalene monooxygenase | 0 | 1 | 0 | 1 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| BH3-interacting domain death agonist | 0 | 1 | 0 | 1 |
| 10 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
| Lactoperoxidase | 0 | 1 | 0 | 2 |
| Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
| Alpha-(1,3)-fucosyltransferase 7 | 0 | 1 | 0 | 1 |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 1 | 0 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
| Thiosulfate sulfurtransferase | 0 | 3 | 0 | 3 |
| 60 kDa chaperonin | 0 | 3 | 0 | 3 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 3 | 0 | 3 |
| 3-oxoacyl-[acyl-carrier-protein] reductase | 0 | 1 | 0 | 1 |
| MAP kinase-activated protein kinase 5 | 0 | 1 | 0 | 1 |
| Histone acetyltransferase KAT2B | 0 | 1 | 0 | 1 |
| Histone acetyltransferase KAT5 | 0 | 1 | 0 | 1 |
| Enoyl-acyl-carrier protein reductase | 0 | 4 | 0 | 4 |
| 3-oxoacyl-acyl-carrier protein reductase | 0 | 2 | 0 | 2 |
| Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | 0 | 2 | 0 | 2 |
| Bcl-2-like protein 10 | 0 | 1 | 0 | 1 |
| Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
| glp-1 receptor, partial | 5 | 0 | 0 | 5 |
| LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 1 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
| nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
| Regulatory protein E2 | 0 | 0 | 1 | 1 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
| DNA topoisomerase 2-alpha | 0 | 1 | 1 | 7 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| DNA topoisomerase 2 | 0 | 0 | 0 | 1 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 1 | 5 |
| Caspase-3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 5 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 5 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 5 |
| DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
| DNA topoisomerase 2-beta | 0 | 1 | 1 | 8 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 5 |
| Integrase | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 5 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 5 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 2 | 0 | 2 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Serine racemase | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 2 | 2 |
| Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
| 15-lipoxygenase, partial | 7 | 0 | 0 | 7 |
| Neuraminidase | 0 | 4 | 0 | 4 |
| Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
| Sialidase | 0 | 2 | 0 | 2 |
| Aromatase | 0 | 2 | 0 | 2 |
| Glutamate receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor 3 | 1 | 0 | 0 | 1 |
| Glutamate receptor 4 | 1 | 0 | 0 | 1 |
| Aurora kinase B | 0 | 2 | 0 | 2 |
| Purine nucleoside phosphorylase | 0 | 2 | 0 | 2 |
| Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 2 |
| Ricin | 0 | 1 | 0 | 1 |
| 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase | 0 | 0 | 1 | 1 |
| Purine nucleoside phosphorylase | 0 | 0 | 1 | 2 |
| Shiga toxin subunit A | 0 | 1 | 0 | 1 |
| Guanine deaminase | 0 | 1 | 0 | 2 |
| Chain A, HISTIDINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Histidine-binding periplasmic protein | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 3 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutaminyl-peptide cyclotransferase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 3 |
| Retinol-binding protein 4 | 0 | 2 | 1 | 3 |
| Cereblon isoform 4 | 0 | 4 | 0 | 4 |
| Bromodomain-containing protein 4 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 0 | 0 | 2 |
| Breakpoint cluster region protein | 0 | 0 | 0 | 2 |
| DNA-binding protein Ikaros | 0 | 0 | 2 | 7 |
| DNA damage-binding protein 1 | 0 | 3 | 2 | 5 |
| Protein cereblon | 0 | 6 | 3 | 14 |
| Zinc finger protein Aiolos | 0 | 0 | 2 | 2 |
| Glucagon-like peptide 1 receptor | 0 | 2 | 2 | 4 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
| Glutathione reductase, mitochondrial | 0 | 3 | 0 | 3 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| NFKB1 protein, partial | 4 | 0 | 0 | 4 |
| DNA polymerase III, partial | 2 | 0 | 0 | 2 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 4 | 0 | 0 | 4 |
| Parkin | 2 | 0 | 0 | 2 |
| hexokinase-4 isoform 1 | 2 | 0 | 0 | 2 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 3 | 0 | 0 | 3 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| glucokinase regulatory protein | 2 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 2 | 0 | 4 |
| Alpha-synuclein | 2 | 2 | 0 | 4 |
| cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
| UDP-glucose 6-dehydrogenase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| UDP-glucose 6-dehydrogenase | 0 | 1 | 0 | 1 |
| Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 0 | 0 | 1 |
| Tumor necrosis factor | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Platelet-activating factor receptor | 1 | 0 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 2 | 0 | 2 |
| Cystine/glutamate transporter | 0 | 1 | 0 | 1 |
| Hydroxyacid oxidase 1 | 0 | 1 | 0 | 1 |
| large T antigen | 0 | 1 | 0 | 1 |
| Androgen receptor | 0 | 3 | 0 | 3 |
| Atrial natriuretic peptide receptor 1 | 0 | 1 | 0 | 1 |
| Chain A, Bacterial leucyl aminopeptidase | 0 | 1 | 0 | 1 |
| 90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
| GALC protein | 1 | 0 | 0 | 1 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 2 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
| Thermolysin | 0 | 2 | 0 | 3 |
| Cholinesterase | 0 | 2 | 0 | 2 |
| Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| Methionine aminopeptidase 2 | 0 | 1 | 0 | 1 |
| Methionine aminopeptidase 1 | 0 | 1 | 0 | 1 |
| Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 1 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| Serine hydroxymethyltransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 3 | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 2 | 0 | 2 | 0 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 2 | 0 | 2 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 2 | 0 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 2 | 0 | 2 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 2 | 0 | 2 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 2 |
| C-X-C chemokine receptor type 4 | 0 | 1 | 0 | 1 |
| Atypical chemokine receptor 3 | 0 | 0 | 1 | 1 |
| C-C chemokine receptor type 2 | 0 | 1 | 0 | 1 |
| C-X-C chemokine receptor type 4 | 0 | 2 | 0 | 4 |
| Programmed cell death protein 1 | 0 | 1 | 0 | 1 |
| E3 ubiquitin-protein ligase ZFP91 | 0 | 0 | 0 | 1 |
| Programmed cell death 1 ligand 1 | 0 | 1 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
| Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 1 |
| Chain A, dATP pyrophosphohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
| Chain B, Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain A, APH(2')-Id | 0 | 1 | 0 | 1 |
| glucose-6-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
| Nrf2 | 1 | 0 | 0 | 1 |
| hexokinase | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
| tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
| Maltase-glucoamylase, intestinal | 0 | 1 | 0 | 1 |
| NUAK family SNF1-like kinase 1 | 0 | 1 | 0 | 1 |
| Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B2 | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 1 | 0 | 1 |
| Cationic trypsin | 0 | 1 | 0 | 1 |
| Chymotrypsin-like elastase family member 1 | 0 | 1 | 0 | 1 |
| Protein E6 | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Interstitial collagenase | 0 | 1 | 1 | 2 |
| Phospholipase A2 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 2 | 1 | 3 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
| Epoxide hydrolase 1 | 0 | 1 | 0 | 1 |
| Trypsin-1 | 0 | 1 | 0 | 1 |
| Trypsin-2 | 0 | 1 | 0 | 1 |
| Procathepsin L | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase Yes | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | 0 | 1 | 0 | 1 |
| Insulin-like growth factor 1 receptor | 0 | 1 | 0 | 1 |
| Stromelysin-1 | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 0 | 1 | 1 |
| Heterogeneous nuclear ribonucleoprotein A1 | 0 | 0 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
| Malate dehydrogenase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 2 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 4 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
| Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B1 | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-9 | 0 | 2 | 0 | 2 |
| Urease subunit alpha | 0 | 3 | 0 | 3 |
| Serine/threonine-protein kinase B-raf | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 2 | 0 | 4 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 4 | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha' | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| 5'-nucleotidase | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| G1/S-specific cyclin-D1 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 2 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 3-kinase regulatory subunit alpha | 0 | 1 | 0 | 1 |
| Cytosol aminopeptidase | 0 | 1 | 0 | 1 |
| ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase receptor UFO | 0 | 1 | 0 | 1 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| RAC-alpha serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
| Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
| Trypsin-3 | 0 | 1 | 0 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 | 0 | 1 | 0 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
| Macrophage metalloelastase | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Glutathione reductase | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase SYK | 0 | 1 | 1 | 2 |
| Collagenase 3 | 0 | 1 | 0 | 1 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0 | 1 | 0 | 1 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 alpha | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 4 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase Nek2 | 0 | 1 | 0 | 1 |
| Oligo-1,6-glucosidase IMA1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase PLK1 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 1 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Anthrax toxin receptor 2 | 0 | 1 | 0 | 1 |
| Casein kinase II subunit beta | 0 | 2 | 0 | 2 |
| Casein kinase II subunit alpha | 0 | 2 | 0 | 2 |
| Urease subunit beta | 0 | 3 | 0 | 3 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 3 | 0 | 4 |
| Cyclin-dependent kinase 6 | 0 | 1 | 0 | 1 |
| Cyclin-dependent-like kinase 5 | 0 | 1 | 0 | 1 |
| Heat shock factor protein 1 | 0 | 1 | 0 | 1 |
| Sorbitol dehydrogenase | 0 | 1 | 0 | 1 |
| Cyclin homolog | 0 | 1 | 0 | 1 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 1 | 0 | 1 |
| Lactoylglutathione lyase | 0 | 2 | 0 | 2 |
| Focal adhesion kinase 1 | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit beta | 0 | 1 | 0 | 1 |
| ELAV-like protein 3 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5 activator 1 | 0 | 1 | 0 | 1 |
| ELAV-like protein 1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase N1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 2 | 1 | 3 |
| Probable maltase-glucoamylase 2 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 2 | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha 3 | 0 | 2 | 0 | 2 |
| Inositol polyphosphate multikinase | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B3 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C21 | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
| Serine/threonine-protein kinase Nek6 | 0 | 1 | 0 | 1 |
| NADPH oxidase 4 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 3 | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 2 | 0 | 1 | 0 | 1 |
| Short transient receptor potential channel 5 | 0 | 1 | 0 | 1 |
| ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 1 | 2 |
| Sialidase-2 | 0 | 1 | 0 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
| Beta-lactoglobulin | 0 | 0 | 1 | 1 |
| Chain A, Activated Factor Xa Heavy Chain | 0 | 1 | 0 | 1 |
| Coagulation factor X | 0 | 2 | 0 | 2 |
| Coagulation factor XII | 0 | 1 | 0 | 1 |
| Suppressor of tumorigenicity 14 protein | 0 | 1 | 0 | 1 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
| Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
| Exportin-1 | 0 | 0 | 1 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| NAD(P)H dehydrogenase [quinone] 1 | 0 | 0 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
| Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
| Plasminogen | 0 | 2 | 1 | 3 |
| procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
| Butyrophilin subfamily 3 member A1 | 0 | 0 | 1 | 2 |
| Geranylgeranyl pyrophosphate synthase | 0 | 2 | 0 | 3 |
| Neutrophil collagenase | 0 | 1 | 0 | 1 |
| Farnesyl diphosphate synthase | 0 | 1 | 0 | 1 |
| Farnesyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
| Geranylgeranyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
| Farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
| H | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |